Xanthine oxidase-IN-13

• UNSPSC Description:

  Xanthine oxidase-IN-13 (Compound 10) is a selective xanthine oxidase inhibitor (IC50: 149.56 μM for bovine xanthine oxidase). Xanthine oxidase-IN-13 can be used for research of inflammatory arthritis[1].

• Target Antigen:

  Xanthine Oxidase

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/xanthine-oxidase-in-13.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC1=CC=C(/N=C/C2=C(O)C=CC=C2)C=C1

• Molecular Weight:

  211.26

• References & Citations:

  [1]Bellahcene F, et al. Unveiling potent Schiff base derivatives with selective xanthine oxidase inhibition: In silico and in vitro approach. Saudi Pharm J. 2024 May;32(5):102062.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported